CIAS
MRNA icon

Capital Investment Advisory Services’s Moderna MRNA Stock Holding History

Capital Investment Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,114
Closed -$200K – 890
2022
Q4 		$200K Buy
+1,114
New +$182K 0.02% 461
2022
Q1 		– Sell
-998
Closed -$253K – 863
2021
Q4 		$253K Buy
998
+275
+38% +$80.4K 0.03% 412
2021
Q3 		$278K Sell
723
-420
-37% -$155K 0.04% 379
2021
Q2 		$269K Buy
+1,143
New +$204K 0.03% 386

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Investment Advisory Services's MRNA Position: Q1 2023 in Review

Capital Investment Advisory Services sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,114 shares — an estimated $200K sold.

Capital Investment Advisory Services first reported a position in MRNA in Q2 2021 and held it in 4 quarters. The position peaked at $278K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Capital Investment Advisory Services reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,114 Moderna shares in Q1 2023, an estimated $200K.
  • Capital Investment Advisory Services first reported a position in Moderna in Q2 2021 and held it in 4 quarters.
  • Capital Investment Advisory Services's Moderna position peaked at $278K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Capital Investment Advisory Services's 13F filing for Q1 2023, filed 21 Apr 2023.